These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18496256

  • 21. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E.
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [Abstract] [Full Text] [Related]

  • 22. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA.
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
    Liberman JN, Berger JE, Lewis M.
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
    [Abstract] [Full Text] [Related]

  • 24. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, Stalla GK, Schmid RM, Kales SN, Mantzoros CS.
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [Abstract] [Full Text] [Related]

  • 25. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D.
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [Abstract] [Full Text] [Related]

  • 26. Glitazones and the cardiovascular system.
    Devchand PR.
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):188-92. PubMed ID: 18316956
    [Abstract] [Full Text] [Related]

  • 27. Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes.
    Toprani A, Fonseca V.
    Diabetes Obes Metab; 2011 Mar; 13(3):276-80. PubMed ID: 21205120
    [Abstract] [Full Text] [Related]

  • 28. [How many and who are receiving medication for diabetes mellitus?].
    Strøm H, Engeland A, Eriksen E, Sakshaug S, Rønning M.
    Tidsskr Nor Laegeforen; 2006 Mar 09; 126(6):768-70. PubMed ID: 16541171
    [Abstract] [Full Text] [Related]

  • 29. Type 2 diabetes mellitus and heart failure.
    Choy CK, Rodgers JE, Nappi JM, Haines ST.
    Pharmacotherapy; 2008 Feb 09; 28(2):170-92. PubMed ID: 18225964
    [Abstract] [Full Text] [Related]

  • 30. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
    De Flines J, Scheen AJ.
    Rev Med Suisse; 2007 Aug 29; 3(122):1876, 1878-83. PubMed ID: 17896661
    [Abstract] [Full Text] [Related]

  • 31. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.
    Gerrits CM, Bhattacharya M, Manthena S, Baran R, Perez A, Kupfer S.
    Pharmacoepidemiol Drug Saf; 2007 Oct 29; 16(10):1065-71. PubMed ID: 17674425
    [Abstract] [Full Text] [Related]

  • 32. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 29; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 33. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
    Lehnert H, Wittchen HU, Pittrow D, Bramlage P, Kirch W, Böhler S, Höfler M, Ritz E.
    Dtsch Med Wochenschr; 2005 Feb 18; 130(7):323-8. PubMed ID: 15712019
    [Abstract] [Full Text] [Related]

  • 34. Actos and Avandia in type 2 diabetes. Where do they fit?
    Clark W.
    Diabetes Self Manag; 2007 Feb 18; 24(4):8, 11-3. PubMed ID: 17663078
    [No Abstract] [Full Text] [Related]

  • 35. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
    Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C, Kelman JA.
    JAMA; 2010 Jul 28; 304(4):411-8. PubMed ID: 20584880
    [Abstract] [Full Text] [Related]

  • 36. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D.
    Diabetes Obes Metab; 2008 Jun 28; 10 Suppl 1():16-24. PubMed ID: 18435670
    [Abstract] [Full Text] [Related]

  • 37. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A.
    Diabetes Metab Res Rev; 2009 Feb 28; 25(2):112-26. PubMed ID: 19219860
    [Abstract] [Full Text] [Related]

  • 38. Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time.
    Wändell PE, Gåfvels C.
    Eur J Clin Pharmacol; 2002 Nov 28; 58(8):547-53. PubMed ID: 12451433
    [Abstract] [Full Text] [Related]

  • 39. The rough road for rosiglitazone.
    Goldfine AB.
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr 28; 15(2):113-7. PubMed ID: 18316944
    [Abstract] [Full Text] [Related]

  • 40. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
    Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G, Diabetes Outcome Progression Trial (ADOPT) Study Group.
    Diabetes Care; 2008 May 28; 31(5):845-51. PubMed ID: 18223031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.